On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
FridayJul 01, 2022 10:30 am

Green Energy Helping Texas Power Grid Withstand Unusually High Demand; Correlate Infrastructure Partners Inc. (CIPI) Supplying Cost-Efficient Solutions for Renewable Energy Options

The current Texas heatwave and the demand on the power grid have reached record numbers, driving more consideration for renewable energy sources like wind and solar power Correlate Infrastructure Partners Inc. offers a complete suite of clean energy assessment solutions for commercial real estate to find the appropriate avenue for incorporating more energy-efficient capabilities The global renewable energy market, valued at $881.7 billion in 2020, is driven by the need to reduce carbon emissions and other greenhouse gasses As unusually high temperatures sweep across the Southwestern U.S., especially Texas, new records for electricity demands are being reached. Texas grid operator…

Continue Reading

FridayJul 01, 2022 9:45 am

Cepton, Inc. (NASDAQ: CPTN) Announces Plans to Boost OEM Initiatives with New Center of Excellence in Detroit and Inclusion in Russell 3000(R) Index

Cepton aims to increase active engagements and initiatives with automotive OEMs with a newly opened office located in Metro Detroit CPTN was added as a member to the Russell 3000(R) Index on June 27, 2022 Cepton is a leading developer of lidar solutions for automotive (ADAS/AV), smart cities, smart spaces, and smart industrial applications CPTN management aims to make lidar a standard safety feature in the cars of today and the key component in the autonomous vehicles of the future Cepton (NASDAQ: CPTN) plans to utilize its new corporate office in Metro Detroit (Troy, MI) to widen its growing engagements…

Continue Reading

FridayJul 01, 2022 9:00 am

Odyssey Health, Inc. (ODYY) Reports Positive Findings on Phase 1 Clinical Trials of PRV-002 for Concussions

No adverse reactions were reported in any of the healthy subjects enrolled in the Cohort II Phase 1 clinical trial of PRV-002  Company in talks with military training sites for Phase 2 and 3 clinical trials on concussed patients The CDC estimates that approximately 1.6 to 3.8 million sports and recreation-related concussions occur annually, for which there is no FDA-approved treatment The global concussion market size was valued at $6.8 billion in 2019. This value is expected to rise to $8.9 billion by 2027, growing at a CAGR of 3.6% Odyssey Health (OTC: ODYY), a medical company focused on unique,…

Continue Reading

Market Basics

New to the micro-cap markets?Get answers to your questions about investing in Small-Cap / Micro-Cap Stocks and learn how to protect yourself.

The Basics

Newsletter Publishers

Have an up and coming newsletter and want to be included in our coverage list? Looking to get more coverage and grow subscriptions? Register for coverage.

Register

Public Companies

Are you a Small-Cap / Micro-Cap company looking for coverage? We'd love to hear from you. Fill out our quick contact form or send us a text.

Get Covered